272 related articles for article (PubMed ID: 26899665)
1. Brivaracetam: First Global Approval.
Markham A
Drugs; 2016 Mar; 76(4):517-22. PubMed ID: 26899665
[TBL] [Abstract][Full Text] [Related]
2. Brivaracetam for the treatment of epilepsy.
Klein P; Tyrlikova I; Brazdil M; Rektor I
Expert Opin Pharmacother; 2016; 17(2):283-95. PubMed ID: 26760311
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of brivaracetam: a new drug to treat epilepsy.
Milovanović JR; Janković SM; Pejčić A; Milosavljević M; Opančina V; Radonjić V; Protrka Z; Kostić M
Expert Opin Pharmacother; 2017 Sep; 18(13):1381-1389. PubMed ID: 28737479
[TBL] [Abstract][Full Text] [Related]
4. Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures.
Kappes JA; Hayes WJ; Strain JD; Farver DK
J Clin Pharmacol; 2017 Jul; 57(7):811-817. PubMed ID: 28394442
[TBL] [Abstract][Full Text] [Related]
5. Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy.
Klein P; Bourikas D
Adv Ther; 2024 Jul; 41(7):2682-2699. PubMed ID: 38811492
[TBL] [Abstract][Full Text] [Related]
6. Brivaracetam: new compound approved for the treatment of epilepsy.
Zaccara G
Drugs Today (Barc); 2016 Apr; 52(4):219-27. PubMed ID: 27252986
[TBL] [Abstract][Full Text] [Related]
7. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.
Gillard M; Fuks B; Leclercq K; Matagne A
Eur J Pharmacol; 2011 Aug; 664(1-3):36-44. PubMed ID: 21575627
[TBL] [Abstract][Full Text] [Related]
9. Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.
Hoy SM
CNS Drugs; 2016 Aug; 30(8):761-72. PubMed ID: 27503181
[TBL] [Abstract][Full Text] [Related]
10. Brivaracetam for the treatment of epilepsy in adults.
Mula M
Expert Rev Neurother; 2014 Apr; 14(4):361-5. PubMed ID: 24625006
[TBL] [Abstract][Full Text] [Related]
11. Brivaracetam UCB.
Malawska B; Kulig K
Curr Opin Investig Drugs; 2005 Jul; 6(7):740-6. PubMed ID: 16044671
[TBL] [Abstract][Full Text] [Related]
12. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H
Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360
[TBL] [Abstract][Full Text] [Related]
13. Brivaracetam: a new drug in development for epilepsy and neuropathic pain.
Malawska B; Kulig K
Expert Opin Investig Drugs; 2008 Mar; 17(3):361-9. PubMed ID: 18321235
[TBL] [Abstract][Full Text] [Related]
14. Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy.
Pollard JR
Curr Opin Investig Drugs; 2008 Jan; 9(1):101-7. PubMed ID: 18183537
[TBL] [Abstract][Full Text] [Related]
15. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.
Mumoli L; Palleria C; Gasparini S; Citraro R; Labate A; Ferlazzo E; Gambardella A; De Sarro G; Russo E
Drug Des Devel Ther; 2015; 9():5719-25. PubMed ID: 26543353
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
[TBL] [Abstract][Full Text] [Related]
17. Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset Seizures.
Schoemaker R; Wade JR; Stockis A
J Clin Pharmacol; 2016 Dec; 56(12):1591-1602. PubMed ID: 27146213
[TBL] [Abstract][Full Text] [Related]
18. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
19. The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy.
Russo E; Citraro R; Mula M
Expert Opin Drug Discov; 2017 Nov; 12(11):1169-1178. PubMed ID: 28829199
[TBL] [Abstract][Full Text] [Related]
20. [Brivaracetam in the treatment of patients with epilepsy].
Karlov VA; Vlasov PN; Zhidkova IA; Kissin MY; Lebedeva AV; Lipatova LV; Mkrtchyan VR; Mukhin KY; Rudakova IG
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9. Vyp. 2):55-62. PubMed ID: 29213040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
